Correlation Between Enliven Therapeutics and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Dermata Therapeutics Warrant, you can compare the effects of market volatilities on Enliven Therapeutics and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Dermata Therapeutics.
Diversification Opportunities for Enliven Therapeutics and Dermata Therapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Enliven and Dermata is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Dermata Therapeutics Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Dermata Therapeutics
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 122.1 times less return on investment than Dermata Therapeutics. But when comparing it to its historical volatility, Enliven Therapeutics is 29.24 times less risky than Dermata Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Dermata Therapeutics Warrant is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 2.00 in Dermata Therapeutics Warrant on September 3, 2024 and sell it today you would lose (1.12) from holding Dermata Therapeutics Warrant or give up 56.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 57.17% |
| Values | Daily Returns |
Enliven Therapeutics vs. Dermata Therapeutics Warrant
Performance |
| Timeline |
| Enliven Therapeutics |
| Dermata Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Enliven Therapeutics and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Dermata Therapeutics
The main advantage of trading using opposite Enliven Therapeutics and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.| Enliven Therapeutics vs. DiaMedica Therapeutics | Enliven Therapeutics vs. Lyra Therapeutics | Enliven Therapeutics vs. Centessa Pharmaceuticals PLC |
| Dermata Therapeutics vs. NLS Pharmaceutics AG | Dermata Therapeutics vs. Dermata Therapeutics | Dermata Therapeutics vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |